GlycoMimetics, Inc.
USE OF HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS FOR TREATING SICKLE CELL DISEASE

Abstract:

Methods for the treatment of sickle cell disease or complications associated therewith, including, for example, vaso-occlusive crisis, by the use of at least one E-selectin inhibitor and compositions comprising the same are disclosed.